20 November 2024
Wilmington plc
Director/PDMR Shareholding
In accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation, Wilmington plc (the 'Company') was advised on 19 November 2024 that:
· Richard Shamsi, a PDMR, sold 1,743 ordinary shares of 5p each in the Company on 19 November 2024 at a price of £3.84 per share. His resultant holding of ordinary shares of 5p each is 83,702 which represent 0.09% of the issued share capital with voting rights.
This sale is to pay the tax liability on the 2021 share awards which vested in October 2024.
For further information, please contact:
Wilmington plc 020 7490 0049
Guy Millward, Company Secretary and Chief Financial Officer
Notes to Editors
Wilmington is the recognised knowledge leader and partner of choice for information, education and networking in Risk & Compliance, Professional and Healthcare areas. Wilmington employs close to 1,000 people and has customers in 120 countries. Wilmington plc is a premium listed Company on the main market of the London Stock Exchange.
|
1. |
Details of the Person Discharging Managerial Responsibility ("PDMR") / person closely associated with them ("PCA")
|
|||||
|
a) |
Name |
RICHARD SHAMSI
|
||||
|
2. |
Reason for the notification
|
|||||
|
a) |
Position /status |
PDMR
|
||||
|
b) |
Initial notification / amendment
|
INITIAL NOTIFICATION |
||||
|
3. |
Details of the Issuer
|
|||||
|
a) |
Name |
WILMINGTON PLC
|
||||
|
b) |
LEI code
|
213800PFUQT4HHFYZJ63 |
||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
ORDINARY SHARES IN WILMINGTON PLC
ISIN: GB0009692319
|
||||
|
b) |
Nature of the transaction |
SALE OF ORDINARY SHARES |
||||
|
c) |
Price(s) and volume(s)
|
|
||||
|
d) |
Aggregated information Aggregated volume Price
|
N/A
|
||||
|
e) |
Date of the transaction |
19 NOVEMBER 2024
|
||||
|
f) |
Place of the transaction |
LONDON
|
||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
